KR20230141819A - 약독화된 아프리카 돼지열병 바이러스 및 백신으로서의 이의 용도 - Google Patents

약독화된 아프리카 돼지열병 바이러스 및 백신으로서의 이의 용도 Download PDF

Info

Publication number
KR20230141819A
KR20230141819A KR1020237029446A KR20237029446A KR20230141819A KR 20230141819 A KR20230141819 A KR 20230141819A KR 1020237029446 A KR1020237029446 A KR 1020237029446A KR 20237029446 A KR20237029446 A KR 20237029446A KR 20230141819 A KR20230141819 A KR 20230141819A
Authority
KR
South Korea
Prior art keywords
virus
asfv
attenuated
strain
asf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237029446A
Other languages
English (en)
Korean (ko)
Inventor
르 포티에 마리-프레데리크 블랏
올리비에 부리
에블린 휴테트
딤나 미레유 르
아멜리에 샤스타그네르
프레데릭 파뵈프
야닉 블랑샤르
피에릭 루카스
Original Assignee
에이젠스 네셔날 데 세큐리트 세니테레 데 랄리망따시옹, 데 랑비론망 에 뒤 트리바이유
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에이젠스 네셔날 데 세큐리트 세니테레 데 랄리망따시옹, 데 랑비론망 에 뒤 트리바이유 filed Critical 에이젠스 네셔날 데 세큐리트 세니테레 데 랄리망따시옹, 데 랑비론망 에 뒤 트리바이유
Publication of KR20230141819A publication Critical patent/KR20230141819A/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/12011—Asfarviridae
    • C12N2710/12021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/12011—Asfarviridae
    • C12N2710/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/12011—Asfarviridae
    • C12N2710/12061—Methods of inactivation or attenuation
    • C12N2710/12062—Methods of inactivation or attenuation by genetic engineering
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/12011—Asfarviridae
    • C12N2710/12071—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020237029446A 2021-02-02 2022-01-31 약독화된 아프리카 돼지열병 바이러스 및 백신으로서의 이의 용도 Pending KR20230141819A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21305138.6 2021-02-02
EP21305138.6A EP4036226A1 (en) 2021-02-02 2021-02-02 Attenuated african swine fever virus and its use as a vaccine
PCT/EP2022/052183 WO2022167360A1 (en) 2021-02-02 2022-01-31 Attenuated african swine fever virus and its use as a vaccine

Publications (1)

Publication Number Publication Date
KR20230141819A true KR20230141819A (ko) 2023-10-10

Family

ID=74661313

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237029446A Pending KR20230141819A (ko) 2021-02-02 2022-01-31 약독화된 아프리카 돼지열병 바이러스 및 백신으로서의 이의 용도

Country Status (10)

Country Link
US (1) US20240123048A1 (cg-RX-API-DMAC10.html)
EP (2) EP4036226A1 (cg-RX-API-DMAC10.html)
JP (1) JP2024504878A (cg-RX-API-DMAC10.html)
KR (1) KR20230141819A (cg-RX-API-DMAC10.html)
CN (1) CN117295815A (cg-RX-API-DMAC10.html)
BR (1) BR112023015579A2 (cg-RX-API-DMAC10.html)
CA (1) CA3207287A1 (cg-RX-API-DMAC10.html)
MX (1) MX2023008932A (cg-RX-API-DMAC10.html)
PH (1) PH12023552004A1 (cg-RX-API-DMAC10.html)
WO (1) WO2022167360A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115851623A (zh) * 2022-12-27 2023-03-28 中国农业科学院兰州兽医研究所 非洲猪瘟mgf505-2r基因缺失减毒株的构建及作为疫苗的应用
CN118091160B (zh) * 2024-03-09 2025-06-06 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) 一种非洲猪瘟病毒抗体的ipma检测方法与试剂盒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR682468A (fr) 1928-12-13 1930-05-28 Gas Fire Extinguisher Corp Du Extincteur d'incendie
GB201410971D0 (en) * 2014-06-19 2014-08-06 Pirbright Inst The Vaccine
US9528094B2 (en) 2014-11-10 2016-12-27 The United States Of America, As Represented By The Secretary Of Agriculture Attenuated African swine fever virus vaccine based in the deletion of MGF genes
CN110093324B (zh) * 2019-04-26 2020-02-18 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) 基因缺失的减毒非洲猪瘟病毒及其作为疫苗的应用

Also Published As

Publication number Publication date
JP2024504878A (ja) 2024-02-01
MX2023008932A (es) 2023-10-10
PH12023552004A1 (en) 2023-12-04
US20240123048A1 (en) 2024-04-18
WO2022167360A1 (en) 2022-08-11
BR112023015579A2 (pt) 2023-11-14
CN117295815A (zh) 2023-12-26
EP4036226A1 (en) 2022-08-03
CA3207287A1 (en) 2022-08-11
EP4288526A1 (en) 2023-12-13

Similar Documents

Publication Publication Date Title
JP7121950B2 (ja) 合理的に開発されたアフリカ豚コレラ弱毒化ウイルス株による、ジョージア2007単離株親ウイルスの攻撃に対する防護
US9528094B2 (en) Attenuated African swine fever virus vaccine based in the deletion of MGF genes
JP7591043B2 (ja) 遺伝子i177lの欠失に基づく新規なアフリカ豚熱弱毒化生ワクチンの開発
CN110093324A (zh) 基因缺失的减毒非洲猪瘟病毒及其作为疫苗的应用
CN112852761B (zh) 基因缺失减毒非洲猪瘟病毒株的构建及作为疫苗的应用
CN112063592A (zh) 非洲猪瘟多基因联合缺失减毒株的构建及作为疫苗的应用
US20260014243A1 (en) Crimean-congo hemorrhagic fever virus replicon particles and use thereof
CN114107228A (zh) 缺失十二个基因的减毒非洲猪瘟病毒株的构建及其作为疫苗的应用
US9463234B2 (en) Attenuated african swine fever virus strain induces protection against challenge with homologous virulent parental virus georgia 2007 isolate
CN114015660A (zh) 缺失十个基因的减毒非洲猪瘟病毒株的构建及其作为疫苗的应用
CN111961654B (zh) 耐热表型稳定遗传、携带负标记的重组口蹄疫病毒无毒株及o/a型口蹄疫二价灭活疫苗
US20250011730A1 (en) Novel porcine rotavirus
CN111748563A (zh) 非洲猪瘟基因缺失弱毒株的构建及其作为疫苗的应用
JP7703030B2 (ja) 安定細胞株において効率的な増殖を可能にする、アフリカ豚熱ワクチンにおけるゲノム欠失
CN117295815A (zh) 减毒非洲猪瘟病毒及其作为疫苗的用途
CN119639691B (zh) 一种非洲猪瘟病毒致弱活疫苗毒株的制备方法及其应用
CN115851623A (zh) 非洲猪瘟mgf505-2r基因缺失减毒株的构建及作为疫苗的应用
Son et al. Whole Yeast Expressing Recombinant Fiber 2 Protein Vaccine Candidate Protects Chicken against Fowl Adenovirus Serotype 4 Infection.
KR20240136420A (ko) 살아있는 약독화된 SARS-CoV-2 및 이의 제조 백신
CN115637260A (zh) 一株表达非洲猪瘟病毒p54基因重组伪狂犬病毒基因工程疫苗及其应用
Ma et al. Sequence Analysis of the SH Gene and Its Flanking Region of a Mumps Virus Strain (SP Strain)
HK40009661A (en) African swine fever attenuated virus strain, vaccine composition and use of the virus strain

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902